Attached files

file filename
EX-23.2 - CONSENT OF PETERSON SULLIVAN - SolarWindow Technologies, Inc.wndw_ex232.htm
EX-24.1 - POWER OF ATTORNEY - SolarWindow Technologies, Inc.wndw_ex241.htm
S-1 - FORM S-1 - SolarWindow Technologies, Inc.wndw_s1.htm

EXHIBIT 5.1

 

[LETTERHEAD]

 

July 29, 2016

 

Board of Directors

SolarWindow Technologies, Inc.

10632 Little Patuxent Parkway, Suite 406

Columbia, Maryland 21044

 

Re:

Registration Statement on Form S-1

 

Gentlemen:

 

We have acted as counsel to SolarWindow Technologies, Inc., a Nevada corporation (the "Company") in connection with the preparation and filing with the United States Securities and Exchange Commission (the "Commission") of the Company's Registration Statement on Form S-1 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Securities Act").

 

The Registration Statement relates to the registration for resale by the selling stockholders named therein (collectively, the "Selling Stockholders") of up to 4,317,500 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), consisting of:

 

(1)

1,539,500 shares of Common Stock (the "Shares") previously purchased by the Selling Stockholders from the Company;

(2)

602,000 shares of Common Stock (the "Series O Shares") issuable upon exercise of outstanding Series O Stock Purchase Warrants (the "Series O Warrants") allowing the holders to purchase shares of Common Stock at an exercise price of $3.10 per share through October 31, 2017;

(3)

301,000 shares of Common Stock (the "Series P Shares") issuable upon exercise of outstanding Series P Stock Purchase Warrants (the "Series P Warrants") allowing the holders to purchase shares of Common Stock at an exercise price of $3.70 per share through April 30, 2018;

(4)

937,500 shares of Common Stock (the "Series Q Shares") issuable upon exercise of outstanding Series Q Stock Purchase Warrants (the "Series Q Warrants") allowing the holders to purchase shares of Common Stock at an exercise price of $3.20 per share through June 20, 2019; and

(5)

937,500 shares of Common Stock (the "Series R Shares") issuable upon exercise of outstanding Series R Stock Purchase Warrants (the "Series R Warrants") allowing the holders to purchase shares of Common Stock at an exercise price of $4.00 per share through June 20, 2021.

 

The Series O Warrants, Series P Warrants, Series Q Warrants and Series R Warrants may hereinafter be collectively referred to as the "Warrants." The Series O Shares, Series P Shares, Series Q Shares and Series R Shares may hereinafter be collectively referred to as the "Warrant Shares."

 

All capitalized terms herein that are not otherwise defined shall have the meaning ascribed thereto in the Registration Statement. In connection with this opinion, we have examined and relied upon the Company's Articles of Incorporation, as amended, the Company's Bylaws, and Registration Statement and related prospectus originals or copies certified or otherwise identified to our satisfaction of all such corporate records of the Company and such other instruments and other certificates of public officials, officers and representatives of the Company and such other persons, and we have made such investigations of law, as we have deemed appropriate as a basis for the opinions expressed below. In addition, we have assumed and have not independently verified the accuracy as to factual matters of each document we have reviewed.

 

 

1

 

 

For the purposes of rendering this opinion, we have examined originals or certified photostatic copies of such other corporate records, agreements, instruments and other documents of the Company as we have deemed relevant and necessary as a basis for the opinion hereinafter set forth. In all such examinations, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of original and certified documents, the due authority of the parties signing such documents, and the conformity to original or certified documents of all copies submitted to us as conformed or reproduction copies.

 

In making our examination of documents executed or to be executed by parties other than the Company, we have assumed that such parties had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof.

 

As to questions of fact relevant to the opinions expressed herein, we have relied without investigation upon, and assumed the accuracy of, certificates and oral or written statements and other information of or from representatives of the Company and others.

 

Based upon and subject to the foregoing, we are of the opinion that:

 

(i)

The Shares have been validly issued, fully paid and non-assessable;

(ii)

the Series O Warrants have been duly authorized for issuance and constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with their terms;

(iii)

upon issuance and delivery of Common Stock representing the Series O Shares against payment therefor in accordance with the terms of the Series O Warrants and upon receipt of the warrant exercise price in accordance with its terms, and when certificates for the Common Stock have been duly executed and countersigned and delivered or other proper evidence of ownership issued, the Series O Shares will be validly issued, fully paid and non-assessable;

(iv)

the Series P Warrants have been duly authorized for issuance and constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with their terms;

(v)

upon issuance and delivery of Common Stock representing the Series P Shares against payment therefor in accordance with the terms of the Series P Warrants and upon receipt of the warrant exercise price in accordance with its terms, and when certificates for the Common Stock have been duly executed and countersigned and delivered or other proper evidence of ownership issued, the Series P Shares will be validly issued, fully paid and non-assessable;

(vi)

the Series Q Warrants have been duly authorized for issuance and constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with their terms;

(vii)

upon issuance and delivery of Common Stock representing the Series Q Shares against payment therefor in accordance with the terms of the Series Q Warrants and upon receipt of the warrant exercise price in accordance with its terms, and when certificates for the Common Stock have been duly executed and countersigned and delivered or other proper evidence of ownership issued, the Series Q Shares will be validly issued, fully paid and non-assessable;

(viii)

the Series R Warrants have been duly authorized for issuance and constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with their terms;

(ix)

upon issuance and delivery of Common Stock representing the Series R Shares against payment therefor in accordance with the terms of the Series R Warrants and upon receipt of the warrant exercise price in accordance with its terms, and when certificates for the Common Stock have been duly executed and countersigned and delivered or other proper evidence of ownership issued, the Series R Shares will be validly issued, fully paid and non-assessable.

 

In rendering the foregoing opinions, we have assumed that: (i) the Company will issue and deliver the Warrant Shares in the manner contemplated by the respective warrant and (ii) the resolutions authorizing the Company to issue the Warrant Shares will be in full force and effect at all times at which the Warrant Shares are issued by the Company.

 

 

2

 

 

The opinions expressed herein are limited by bankruptcy, insolvency, reorganization, fraudulent transfer and fraudulent conveyance, voidable preference, moratorium or other similar laws and related regulations and judicial doctrines from time to time in effect relating to or affecting creditors' rights generally, and by general equitable principles and public policy considerations, whether such principles and considerations are considered in a proceeding at law or at equity.

 

The opinions expressed herein are limited exclusively to (i) the Nevada Revised Statutes (the "NRS"), applicable provisions of the Nevada Constitution and judicial decisions interpreting the NRS and such provisions of the Nevada Constitution, (ii) as to the enforceability of the Warrants against the Company, the laws of the State of New York, and we have not considered, and express no opinion on, any other laws or the laws of any other jurisdiction and (iii) the federal securities laws of the United States of America. We assume no obligation to supplement this opinion if any applicable laws change after the date of this letter with possible retroactive effect, or if any facts or events occur or come to our attention after the date of this letter that might change any of the opinions expressed above.

 

We consent to the filing of this legal opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the headings "Legal Matters" in the prospectus that forms a part of the Registration Statement and "Legal Matters" in any prospectus supplement that will form a part of the Registration Statement. In giving such consent, we do not hereby concede that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission thereunder. This opinion is furnished by us, as counsel to the Company, in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act and, except as provided in this paragraph, is not to be used, circulated or quoted for any other purpose. This opinion supersedes and replaces all prior opinions regarding the subject matter hereof.

 

Very truly yours,

 

/s/ Sierchio & Partners, LLP                               

 

 

3